ANIMATION

Curosurf Intratracheal Suspension

Share this animation:

Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, which may result in atelectesis. Curosurf (poractant alfa) is an intratracheal surfactant suspension indicated for the rescue treatment of premature infants suffering from RDS.

Share It:
Contact XVIVO

Client


Cornerstone Therapeutics

The animations that we developed with XVIVO garnered international acclaim and received praise from renowned dermatology experts.

Vice President, Management Supervisor, Ogilvy Healthworld Medical Education
Share this animation: